Use of Janus Kinase Inhibitors for Granulomatous Dermatoses: A Systematic Review
Published: 16 March 2023| Version 2 | DOI: 10.17632/rx3mnmjs24.2
Contributor:
Siddhartha Sood
Description
Granulomatous dermatoses (GDs) are heterogeneous inflammatory skin conditions involving granuloma formation and macrophage accumulation. While the use of Janus kinase inhibitors (JAKi) for GDs remains novel, this systematic review summarizes the current evidence regarding efficacy and safety of JAKi for CGDs.
Files
Categories
Dermatology